CareDx (CDNA) Tops Q2 EPS by 36c, beats revenue

CareDx (NASDAQ: CDNA) reported Q2 EPS of ($0.18), $0.36 better than the analyst estimate of ($0.54). Revenue for the quarter came in at $70.3 million versus the consensus estimate of $61.77 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• HCB shareholders approve Independent Bank's acquisition deal
• CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress